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INTRODUCTION
Sudden cardiac death (SCD) related to ventricular
tachyarrhythmia in young athletes is a dramatic event
that has emotional and social impact on the media and
the medical community. Ventricular ectopic beats (VEB),
even with frequent and/or complex forms, have fre-
quently been described on 24-hour ECG in 25-65% of
athletes. For athletes with ventricular arrhythmias who
have no evidence of underlying heart disease or who
have an unsuspected cardiovascular disease, identify-
ing subjects at risk of serious ventricular tachyarrhyth-
mias is often problematic. Corrado et al (1) reported
that, while sporting activity is not the cause of sudden
cardiac death, it can trigger cardiac arrest in subjects
whose cardiovascular conditions engender a risk of life-
threatening arrhythmias during athletic activity. Fre-
quent ventricular premature beats with complex mor-
phology and couplets and non-sustained ventricular
tachycardia (NSVT) may be detected in a competitive
athlete during ambulatory clinical screening, without
evidence of underlying cardiovascular disease. Despite
the increased availability of non-invasive and invasive
clinical diagnostic methods, such cases pose a diag-
nostic dilemma for physicians called upon to assess the
subject’s eligibility to practice sport. It is necessary to
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ABSTRACT: Introduction: Aim of our study is to evaluate the role of TWA to stratify the risk of
sudden cardiac death in athletes (Ath) with complex ventricular arrhythmias (VA), and to docu-
ment a possible correlation between TWA and electrophysiological testing (EES) results.
Methods: We studied 43 Ath with VA (31 M, mean age 34 ± 12 years). In all cases a cardiological
evaluation was performed, including TWA and EES. The patients were evaluated during a follow-
up of 25 ± 22 months. The end-point was the occurrence of sudden death or malignant ventric-
ular tachyarrhythmias (VT). 
Results: TWA was negative in 28 Ath (65%), positive in 8 (19%) and indeterminate in 7 (16%). All
subjects with negative TWA did not show induction of VT at EES, with significant correlation be-
tween negative TWA and negative EES (p<0.001). All Ath with positive TWA also had VT induced
by a EES, but without significant correlation between positive TWA and positive EES. In 2 Ath
with undetermined TWA (29%) VT were induced at EES. Our data did not show significant cor-
relation between indeterminate TWA and positive or negative EES. However, logistic regression
analysis showed significant correlation between abnormal TWA test (positive or indeterminate)
and inducibility of VT at EES (p<0.001). During follow-up we observed a significant difference in
end-point occurrence between Ath with negative or positive TWA and between Ath with nega-
tive or positive EES. 
Conclusion: TWA confirm its role as a simple and non-invasive test, and it seems useful for prog-
nostic stratification of Ath with VA. (Heart International 2007; 3: 58-67)
KEY WORDS: T-wave alternans, Sudden death, Ventricular arrhythmias, Sport activity
1Department of Cardiology, Ospedale Maggiore, Crema - Italy
2Department of Information Technologies, University of Milan, Milan - ItalyInama et al
59
make a precise differential diagnosis between an ex-
pression of athlete’s heart, which may mimic cardiovas-
cular disease, and “silent” cardiovascular abnormalities
that may progress to sustained tachyarrhythmias and/or
sudden death with long-term intensive training. Sys-
tematic diagnostic methods, including ECG, Holter
monitoring, stress testing and echocardiography, are
sometimes unable to reveal an underlying structural
heart disease, and further evaluations are required in or-
der to determine whether the arrhythmia is benign or
potentially life-threatening. Many non-invasive markers
of SCD, such as depressed left ventricular ejection frac-
tion, late potentials, QT dispersion, heart rate variability
and baroreflex sensitivity, play a role in risk stratifica-
tion, but are limited by their low specificity. It is crucial
to precisely identify athletes at increased risk for seri-
ous ventricular tachyarrhythmias in order to exclude
them from competitive sport and implement an effective
strategy to prevent sudden cardiac death. 
Specific forms of electrocardiographic alternans re-
lated to cardiac repolarization abnormalities have re-
cently emerged as a cause of serious ventricular ar-
rhythmias. In the 1980s, Adam and Smith (2,3) devel-
oped the spectral analysis method for detecting micro-
volt T-wave alternans in experimental animals and, sub-
sequently, in humans (4,5). These studies showed that
microvolt T-wave alternans is a reliable non-invasive
risk marker of cardiac electrical vulnerability and a pre-
dictor of ventricular arrhythmias (4-13). Electrical alter-
nans is defined as beat-to-beat variation in the vector,
amplitude and/or morphology of electrocardiographic
signals, due to localized alternation in action potential
duration. The presence of amplitude alternans of the T-
wave at a periodicity of 0.5 cycles/beat defines T-wave
alternans. T-wave alternans (TWA) is a promising new
non-invasive clinical tool for identifying patients at risk
for sudden cardiac death in a diverse patient popula-
tion. The usefulness of TWA in predicting the risk of ven-
tricular tachyarrhythmias has been widely reported in
several clinical conditions, including coronary artery
disease, non-ischemic cardiomyopathy, congestive
heart failure and in patients with implantable cardiac de-
fibrillators (14). Recently, several authors have docu-
mented the high negative predictive value of TWA in pa-
tients with heart disease and low ejection fraction
(15,16). 
The aim of our study was to evaluate the predictive
value of T-wave alternans in stratifying the risk of severe
ventricular tachyarrhythmias and sudden cardiac death
in athletes with ventricular arrhythmias, and to investi-
gate the relationship between TWA and the results of
programmed ventricular stimulation during electrophys-
iologic endocavitary  study. 
MATERIAL AND METHODS
Study protocol
In this prospective study, we enrolled 43 consecutive
athletes (31 males, 12 females), with no history of car-
diovascular disease, with age 34 + 11 years  involved in
different types of sports. All subjects had been referred
to our Cardiology Department following the detection of
ventricular arrhythmias during eligibility screening for
competitive sports. These arrhythmias included fre-
quent premature ventricular complexes (PVC), arbitrari-
ly defined as PVC > 2,000 on 24-h ambulatory Holter
monitoring (28 athletes), or NSVT (13 athletes) or sus-
tained ventricular tachycardia (SVT) (2 athletes). All pa-
tients underwent a basic cardiological evaluation, which
consisted of anamnesis, physical examination, routine
blood tests (including fT3, fT4, TSH), ECG, Holter
recording, echocardiogram and maximal exercise test.
Furthermore, pharmacological testing, specific blood
test for myocarditis, coronary angiogram, right and left
ventriculogram, magnetic resonance imaging and en-
domyocardial biopsy were performed, depending on
the basic cardiological evaluation. All athletes then un-
derwent electrophysiologic study (EES) with pro-
grammed ventricular stimulation (PVS) and microvolt T-
wave alternans (TWA) testing. Informed consent was
obtained from each subject.
T-wave alternans test
T-wave alternans was measured during a bicycle ex-
ercise test after careful skin preparation, including mild
abrasion, and placement of high-resolution electrodes
(Microvolt Sensors, Cambridge Heart, Inc., Bedford,
MA) in order to minimize signal noise. Electrocardio-
graphic leads were placed in the standard 12-lead posi-
tions and in a Frank orthogonal configuration (X,Y,Z).
Electrocardiographic signals were amplified and digital-T-wave alternans in athletes
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ized, and measurements were taken by means of the
CH2000 System (Cambridge Heart, Inc., Bedford, MA)
using the spectral method. This technique involved mea-
suring the amplitudes of corresponding points in 128
consecutive T-waves, at the same time after the QRS
complex. The amplitude fluctuation was then subjected
to spectral analysis. The software then calculated: 
1) the alternans voltage (Valt), defined as the difference
in voltage between the overall mean beats and either
the even-numbered or odd-numbered mean beats;
2) the alternans ratio (K), a measure of the significance
of microvolt TWA, defined as the ratio of alternans
power divided by the standard deviation of the noise
in the reference frequency band. A K > 3 was consid-
ered to be significant.
TWA was classified as positive if it was sustained
(duration > 1 min) with onset at heart rate < 110 bpm,
Valt > 1.9  V  and K > 3. TWA was considered negative if
it did not meet the positivity criteria and if at least 1
minute of artifact-free data was available at heart rate >
105 bpm. Otherwise, the test was classified as indeter-
minate.
Positive or indetermined T-wave alternans test were
considered as an abnormal result (16). 
Electrophysiologic study 
Electrophysiologic study was performed in the non-
sedated, postabsorptive state. A 6-French tetrapolar
recording and stimulating catheter was inserted through
the right femoral vein and positioned in the right ventri-
cle. A venous access was created in the right femoral
vein and a venous introducer was inserted. Thereafter, a
quadripolar catheter was advanced to the right ventric-
ular apex under fluoroscopic control and ECG monitor-
ing. Programmed ventricular stimulation was performed
through an automatic stimulator (Micropace EPS 320)
with up to three extrastimuli at three drive cycle lengths
(600, 500, 400 msec). The same protocol was then re-
peated with the catheter placed in the right ventricular
outflow tract. EES was considered positive if SVT or
ventricular fibrillation (VF) was induced.
Follow up
All patients were directly evaluated every 6 months
and in the event of symptoms. The occurrence of seri-
ous ventricular arrhythmias (SVT or VF) or SCD was re-
garded as the end-point. SCD was defined as unex-
pected death occurring within 1 hour of the onset of
symptoms or during sleep. The mean follow up was  25
+ 22 months.
Statistical analysis 
The data were firstly processed using a hierarchical
clustering procedure, in order to highlight possible dif-
ferences among  groups of the main available variables
(age, sex, ejection fraction, sports activity, clinical pre-
sentation) in relationship with the TWA (positive, nega-
tive and indeterminate) and EES (positive and negative)
variables.
In the following we carried out a set of  logistic re-
gression analyses where the dependent dichotomous
variables were respectively TWA (positive, negative and
indeterminate) and EES (positive and negative), to eva-
luate the significance of the differences among groups
pointed out by the clustering procedure.  
Finally, in order to establish a possible significant in-
fluence of the TWA and EES variables on the time free
from malignant arrhythmic events, we evaluated the fol-
low-up data by generating Kaplan-Meier survival curves
where the endpoint was the occurrence of a malignant
ventricular arrhythmias and the grouping variables were
TWA (positive, negative and indeterminate)  and EES
(positive and negative).
RESULTS
At the end of cardiological screening, a structural
heart disease was identified in 7 patients (16%). Specif-
ically, arrhythmogenic right ventricular dysplasia was
diagnosed in 3 patients and myocarditis in 2. The diag-
nosis of myocarditis was made on the basis of magnet-
ic resonance imaging, which showed areas of hyper-en-
hancement with “patchy” distribution, and was con-
firmed by endomyocardial biopsy. Furthermore, in 2 pa-
tients, the echocardiographic picture was borderline for
the diagnosis of early-stage dilated cardiomyopathy.
Pharmacological antiarrhythmic therapy was started in
15 patients (35%): 7 (47%) were affected by structural
heart disease, while in 8 (53%) there was no diagnosis
of evident heart disease, therapy being started becauseInama et al
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the patients were heavily symptomatic for palpitations.
Antiarrhythmic therapy consisted of amiodarone in 7
patients (47%), beta blockers in 3 (20%), sotalol in 3
(20%) and an association of amiodarone and beta
blockers in 2 (13%). After cardiological evaluation, an
ICD was implanted in 4 subjects (9%): 3 affected by ar-
rhythmogenic right ventricular dysplasia and 1 with my-
ocarditis (Fig. 1). 
Microvolt-TWA test 
Microvolt-TWA testing proved negative in 28 patients
(65%), positive in 8 (19%) and indeterminate because of
excessive noise in 7 (16%) (Fig. 2). Therefore, 15 pa-
tients (35%) showed abnormal microvolt-TWA testing.
There were no significant differences between patients
with positive, indetermined or negative TWA in terms of
age, sex, ejection fraction, sports activity, and clinical
presentation (Tab. I).   
Electrophysiologic study
Malignant ventricular arrhythmias were induced
through programmed ventricular stimulation in 10 pa-
tients (23%), and were not induced in 33 (77%) (Fig. 3).
There were no significant differences between these pa-
tients in terms of age, sex, clinical presentation, ejection
fraction, sports activity and clinical presentation. 
Correlation between TWA test and electrophy-
siologic study
Malignant ventricular arrhythmias were not inducible
during electrophysiologic study in any of the subjects in
whom the TWA test was negative. Logistic regression
analysis demonstrated a significant correlation between
a negative microvolt-TWA test and non-inducibility of
ventricular arrhythmias during electrophysiologic study
(p<0.001). In contrast, in all patients with a positive TWA
test, ventricular tachyarrhythmias were inducible during
Fig. 1 - Results of TWA test and EES and occurrence of sponta-
neous ventricular arrhythmias during follow-up in study population.
In brackets it is specified the number of patients who received ICD.
Fig. 2 - Positive TWA test in a 23-year-old male athlete with ven-
tricular arrhythmias.T-wave alternans in athletes
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electrophysiologic study (SVT requiring external defib-
rillation in 6 patients and ventricular fibrillation in 2 pa-
tients). However, logistic regression analysis did not
show a significant correlation between a positive TWA
test and inducibility of ventricular arrhythmias during
electrophysiologic study. Of the patients in whom the
TWA test was indeterminate, 2 (29%) showed inducibil-
ity of ventricular arrhythmias during electrophysiologic
study (sustained ventricular tachycardia requiring exter-
nal defibrillation in all patients), while in 5 (71%) the
Fig. 3 - Induction of VF during
programmed ventricular stimula-
tion (double extrastimulus) in the
same patient of Figure 2.
TABLE I - COMPARISON OF CLINICAL AND DEMOGRAPHIC CHARACTERISTICS BETWEEN PATIENTS WITH NEGATIVE, INDETERMI-
NATE AND POSITIVE TWA
Negative Indeterminate Positive p
TWA TWA TWA
Age 34 ± 13 33 ± 10 34 ± 9 p=NS
Males 21 (75%) 4 (57%) 6 (75%) p=NS
Sport
- Soccer 5 (18%) 2 (28%) 2 (25%) p=NS
- Running 7 (25%) 3 (44%) 2 (25%) p=NS
- Skiing 2 (7%) 1 (14%) 0 (0%) p=NS
- Cycling 4 (14%) 1 (14%) 2 (25%) p=NS
- Motorcycling 1 (4%) 0 (0%) 0 (0%) p=NS
- Volleyball                4 (14%) 0 (0%) 1 (12.5%) p=NS
- Swimming   4 (14%) 0 (0%)  0 (0%)  p=NS
- Climbing 1 (4%)  0 (0%) 0 (0%) p=NS
- Gymnastics              0 (0%) 0 (0%) 1 (12.5%)  p=NS         
EF (%) 66 ± 5 66 ± 5 65 ± 4 p=NS
Arrhythmias
- VEBs 19 (68%) 5 (71%) 4 (50%)    p=NS  
- NSVTs    9 (32%) 2 (29%)  2 (25%) p=NS
- SVTs 0 (0%) 0 (0%) 2 (25%) p=NSInama et al
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electrophysiologic study was negative. Logistic regres-
sion analysis did not show a significant correlation be-
tween an indeterminate TWA test and inducibility or
non-inducibility of ventricular arrhythmias during elec-
trophysiologic study (p>0.05). However, logistic regres-
sion analysis showed significant correlation between
abnormal TWA test (positive or indeterminate) and in-
ducibility of ventricular arrhythmias at electrophysiolog-
ic study (p<0.001). Our data demonstrate that the TWA
test has a positive predictive value (PPV) of 100% for
positive TWA test and of 67% for abnormal TWA, and a
negative predictive value (NPV) of 100% in predicting
the inducibility of ventricular arrhythmias during electro-
physiologic study (Tab. II).
Follow up
During a mean follow-up of 25 months, 3 patients
(7%) experienced an arrhythmic event regarded as the
end-point of the study (VF in 1 patient, SVT in 1 and
Fig. 4 - Kaplan-Meier
survival curves com-
paring end-point oc-
currence between pa-
tients with negative, in-
determinate and posi-
tive TWA.
Fig. 5 - Kaplan-Meier
survival curves com-
paring end-point oc-
currence between pa-
tients with negative
and positive EES.
TABLE II - CORRELATION BETWEEN TWA TEST AND ELEC-
TROPHYSIOLOGIC STUDY
Negative Positive p
EES EES
Negative TWA 28 (100%) 0 (0%) p<0.001
Indeterminate TWA 5 (71%) 2 (29%) p=NS
Positive TWA 0 (0%) 8 (100%) p=NS
Abnormal TWA 5 (33%) 10 (67%) p<0.001
(Indeterminate + Positive)T-wave alternans in athletes
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both arrhythmias in 1). The difference in end-point oc-
currence rate was significant between patients with a
negative TWA test (0%) and those with a positive TWA
test (37.5%) (p<0.01). The difference in end-point oc-
currence was significant also considering patients with
negative (0%) or abnormal TWA test (20%) (p<0.05). In
our study, the TWA test predicted the occurrence of ma-
lignant ventricular arrhythmias with an NPV of 100%
and a PPV of 37.5% for positive TWA and 20% for ab-
normal TWA (Fig. 4). 
Similarly, there was a significant difference in end-
point occurrence rate between patients in whom the
electrophysiologic study proved positive and those in
whom it was negative (30% vs 0%) (p<0.01). The elec-
trophysiologic study predicted the occurrence of malig-
nant ventricular arrhythmias with an NPV of 100% and a
PPV of 30% (Fig. 5).
DISCUSSION
Ventricular ectopic beats have been detected by sur-
face electrocardiogram in 1% of the general population,
and by 24-hour ambulatory ECG Holter monitoring in
40% to 75% of apparently healthy subjects (16-19).
However, athletes constitute a particular population of
healthy people, in that they show a high prevalence of
morphological cardiac alterations (a condition known as
athlete’s heart), electrocardiographic abnormalities
(wave voltage modification, ST and T wave changes)
and frequent and/or complex ventricular beats. Ath-
letes’ hearts undergo morphological adaptations which
can mimic a cardiovascular disease. Consequently, it is
not easy to make a differential diagnosis with heart dis-
eases at  risk of sudden death, such as, for example, hy-
pertrophic and dilated cardiomyopathy and arrhythmo-
genic right ventricular cardiomyopathy, which are often
difficult to diagnose in their initial phase. The onset of
these alterations in the athlete’s heart can be due to
adaptation to dynamic sports activity and the impact of
training on cardiac cavity size. Several prospective
studies have shown that detraining and physical de-
conditioning can result in cardiac reverse remodeling,
with a reduction in cavity size, and in the reversibility of
ventricular arrhythmias, which is complete in about
25% of subjects and partial in 50% (20-22). Biffi et al
(23) reported that the presence of frequent and/or com-
plex ventricular beats in competitive athletes did not in-
dicate an adverse prognosis in subjects without under-
lying structural heart disease. Nevertheless, the detec-
tion of frequent and complex ventricular arrhythmias in
a competitive athlete requires particular attention on the
part of cardiologists and sports physicians in order to
determine whether these arrhythmias have a good
prognosis or are potentially life-threatening. In recent
studies, several authors have reported that competitive
athletes with silent arrhythmogenic heart disease have a
higher risk of sudden death than sedentary subjects of
the same age and with a similar latent cardiac substrate
(24-27). 
When frequent and complex ventricular arrhythmias
are diagnosed in a young athlete, physicians are faced
with medical, ethical and legal problems. Firstly, it is
mandatory to clarify whether there is an undiagnosed
structural heart disease. If diagnostic screening does
not demonstrate the presence of heart disease, there
are other issues to consider: the role of intense training
on the arrhythmic pattern in young athletes and the po-
tential usefulness of detraining, the criteria of eligibility
for sports activity, the importance of the athlete’s own
wishes and the pressure exerted by family members
and coaches. 
The value of TWA in predicting ventricular tach-
yarrhythmias in patients with congestive heart failure
and with previous myocardial infarction has been evalu-
ated in several clinical studies (7, 13, 28). These reports
document a highly significant statistical association be-
tween positive TWA and ventricular tachyarrhythmic
events. Gehi et al (29) recently conducted a meta-analy-
sis of the results of 19 studies carried out on a wide
range of subjects, including those with ischemic or non-
ischemic congestive heart failure, coronary artery dis-
ease, athletes and healthy individuals. These authors
found that the risk of tachyarrhythmic events was near-
ly four-fold higher in subjects in whom TWA testing was
positive than in those in whom it was negative, and that
there was no difference between patients with ischemic
or non-ischemic heart failure. The positive predictive
value of TWA varied in the meta-analysis from 0% to
51%, depending on the patient population studied,
while the negative predictive value was 97% (29). Very
few data are available on the risk stratification of sud-
den cardiac death and severe ventricular tachyarrhyth-
mic events in athletes with ventricular arrhythymias. In aInama et al
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multi-center study of 52 competitive athletes with se-
vere arrhythymias, Furlanello et al (27) found a high neg-
ative predictive value of TWA when both programmed
ventricular stimulation and follow up were used as end-
points. Unfortunately, the limited number of athletes
with positive TWA in this study did not allow to obtain a
significant positive predictive value.
In our population of athletes undergoing TWA evalua-
tion and programmed ventricular stimulation, we docu-
mented a significant correlation between TWA test neg-
ativity and non-inducibility of ventricular arrhythmias
through programmed ventricular stimulation. In con-
trast, our study did not show a significant correlation
between positive or indeterminate TWA testing and the
result of electrophysiologic study, although we found a
non-significant trend towards correlation with inducibil-
ity of ventricular arrhythmias. However, this correlation
become significant if we consider patients with abnor-
mal TWA (positive and indeterminate). The pathophysi-
ological reason for this trend may be that TWA testing
often proves indeterminate in patients with very fre-
quent and complex ventricular ectopic beats; in such
subjects, programmed ventricular stimulation can in-
duce ventricular arrhythmias, and arrhythmic events
may occur during follow up. 
In our study, TWA testing showed a very high NPV
(100%) and PPV (100% for positive TWA and 67% for
abnormal TWA) in predicting the result of programmed
ventricular stimulation. However, a larger study popula-
tion may be needed in order to demonstrate a signifi-
cant correlation between positive and indeterminate
TWA testing and inducibility of ventricular arrhythmias
during electrophysiologic study. 
Comparison between TWA and programmed
ventricular stimulation in different populations
Review of a number of prospective studies conduct-
ed in a variety of clinical patient populations, including
subjects with non-ischemic or ischemic cardiac dis-
ease, syncope, dilated cardiomyopathy and congestive
heart failure, suggests that the occurrence rate of se-
vere ventricular tachyarrhythmias in patients with posi-
tive TWA is equivalent to that of ventricular tach-
yarrhythmias in patients with a positive result on pro-
grammed ventricular stimulation during  electrophysio-
logic endocavitary study. The event rate among patients
with negative TWA is low, and in many cases lower than
the event rate in patients with a negative response to pro-
grammed ventricular stimulation (7,12,13,28). Rosen-
baum et al (4) evaluated T wave alternans as a predictor
of severe arrhythmic events in a group of 83 patients who
underwent programmed ventricular stimulation for previ-
ous tachyarrhythmic events. During a follow-up of 20
months, Kaplan-Meier survival analysis showed that
TWA had a good predictive value, in that the rates of ar-
rhythmia-free survival were 94% in patients with negative
TWA and 19% in those with positive TWA. 
In a multi-center trial of 313 patients undergoing pro-
grammed ventricular stimulation and TWA testing, Gold
et al (7) documented that TWA was a highly significant
predictor of major ventricular tachyarrhythmias. During
follow up, the presence of positive TWA was associated
with a relative risk of 10.9, versus 7.1 for EES and 4.5 for
signal-averaged electrocardiography (SAECG), for the
end-point of sudden cardiac death and sustained ven-
tricular tachycardia, ventricular fibrillation or ICD im-
plantation. In many studies, TWA has proved to be
equivalent to programmed ventricular stimulation and
better than SAECG in the risk stratification of patients
for life-threatening arrhythmias (4, 7, 11, 30-32).  
In our study we found a significant difference between
patients with positive and negative TWA tests with regard
to the occurrence of sudden death, ventricular fibrillation
and sustained ventricular tachycardia during an average
follow-up of 25 months. Kaplan-Meier survival analysis
showed a 100% rate of end-point-free survival in patients
with a negative TWA test and a 62.5% rate in subjects
with a positive TWA test, suggesting that TWA can also
predict spontaneous malignant arrhythmic events in ath-
letes with ventricular arrhythmias. The difference was
significant also considering patients with abnormal TWA,
in whom there was a 80% rate of end-point-free survival.
The NPV (100%) and PPV (37.5% for positive TWA test
and 20% for abnormal TWA test) obtained in our study
are comparable to those reported by Gehi et al (29) in dif-
ferent populations.
TWA and programmed ventricular stimulation
in competitive athletes
Few studies have evaluated T wave alternans as a
predictor of arrhythmic events in competitive athletes,
and little information is available on the comparison ofT-wave alternans in athletes
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TWA and programmed ventricular stimulation in arrhyth-
mia risk stratification in this population (27). In our
study, the predictive accuracy of invasive programmed
ventricular stimulation during EES was similar to that of
TWA. These results, which were obtained in a single-
center experience, are in line with those from a multi-
center study by Furlanello et al (27) on 52 competitive
athletes, and suggest that TWA may play an important
role in the prognostic stratification of athletes with ven-
tricular arrhythmias. Unlike electrophysiological study,
which is an invasive procedure requiring hospitalization,
TWA testing is non-invasive, cheap, easy to perform
and repeatable during follow-up. 
CONCLUSION
TWA is an effective non-invasive predictor of the risk
of severe ventricular tachyarrhythmias and sudden car-
diac death in competitive athletes, its efficacy being at
least comparable to that of invasive programmed ven-
tricular stimulation. In particular, T wave alternans has a
high negative predictive value. In athletes with ventricu-
lar arrhythmias TWA seems to be useful for improving
risk stratification for sudden cardiac death.   
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